Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF), which is developing a new class of synthetic anti-infectives, has been awarded an Advanced Overseas Finding...

Related Keywords

Australia ,Australian ,James Graham ,Rd Tax Incentive Program ,Synthetic Antibiotic Research Development ,Department Of Industry ,Australian Government Department Of Industry ,Recce Pharmaceuticals Ltd ,Recce Pharmaceuticals ,Advanced Overseas Finding ,Synthetic Antibiotic Research ,Australian Government ,